MedTrace Logo

Myeloproliferative Neoplasms (MPNs) Patient Registry

NCT02760238 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-08-27

No results posted yet for this study

Summary

The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.

Conditions

  • Primary Myelofibrosis
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Mastocytosis
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
  • Leukemia, Myelomonocytic, Juvenile
  • Chronic Eosinophilic Leukemia-not Otherwise Specified
  • Myelodysplastic-Myeloproliferative Diseases
  • Neoplasms
  • Leukemia, Myelomonocytic, Chronic

Interventions

OTHER

Observational

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Vikas Gupta, MD · University Health Network, Toronto

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02760238 on ClinicalTrials.gov